Day 1

PFO Closure: Lessons from the Clinical Trials

solaci
solaci
525
0

3_alejandro_fernandez

Fernandez, Alejandro Diego (Argentina)
2014-04-23

Previous article
How to manage complications: Technical aspects of pericardiocentesis
Next article
Technical refinements of Aortic Valvuloplasty in non TAVI Candidates
solaci
solaci

More articles by this author

How to manage complications: Technical aspects of pericardiocentesis

solaci - 0
Palacios, Igor (USA)2014-04-23

Technical refinements of Aortic Valvuloplasty in non TAVI Candidates

solaci - 0
Dager, Antonio (Colombia)2014-04-23

Aortic Valvuloplasty in the era of TAVI:Results and outcomes of 500 patients at WHC

solaci - 0
Pichard, Augusto (USA)2014-04-23

Improving safety and efficacy: LAA closure step by step

solaci - 0
Quesada, Ramón (USA)2014-04-23

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

Dr. Andrés Rodríguez - 0
The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Dr. Juan Manuel Pérez - 0
Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

Dr. Juan Manuel Pérez - 0
The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...